SCIENTURE HOLDINGS, INC. Convertible Notes Payable, Noncurrent
SCIENTURE HOLDINGS, INC. (SCNX) had Convertible Notes Payable, Noncurrent of $1.58 million as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2026-03-30
- 2025-06-30: Convertible Notes Payable, Noncurrent $1.58M.
- 2025-03-31: Convertible Notes Payable, Noncurrent $1.09M.
- 2024-12-31: Convertible Notes Payable, Noncurrent $612.27K.
- 2024-09-30: Convertible Notes Payable, Noncurrent $2.26M.
| Period end | Convertible Notes Payable, Noncurrent | Convertible Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2025-06-30 | $1.58M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $612.27K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.26M 10-Q · filed 2024-11-06 | |
| 2018-06-30 | $100.00K 10-Q · filed 2018-07-27 | |
| 2017-12-31 | $181.50K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $181.50K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $181.50K 10-Q · filed 2017-08-04 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-02 | $10.59K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |